The prognostic value of cadherin switch in bladder cancer.

Loss of E-cadherin expression and gain of N-cadherin expression ('cadherin switch') is shown to be characteristic in epithelial to mesenchymal transition (EMT), a mechanism associated with cancer progression. Furthermore, the prognostic role of P-cadherin in different cancers is controversial. The aim of this study was to evaluate the prognostic significance of 'cadherin switch' on the gene expression level in bladder cancer. Frozen tissue samples of 181 bladder cancer patients and 7 control individuals were analyzed by quantitative real-time PCR. Kaplan-Meier log-rank test and Cox univariate and multivariate analysis were performed to assess the prognostic relevance of gene expression of E-, N- and P-cadherin. Cox univariate analysis revealed that the decrease of E-cadherin and the gain of N-cadherin gene expression are risk factors for cancer-related death (P=0.087, P=0.005, respectively). Fourteen percent (13/92) of muscle-invasive bladder cancers were N-cadherin- negative. These patients had a significantly poorer prognosis than those with N-cadherin-positive muscle-invasive tumors (P=0.024). P-cadherin gene expression proved to be a significant independent prognostic factor for both cancer-specific and recurrence-free survival (P=0.011, P=0.036). The characteristic 'cadherin switch' between low- and high-stage tumors that we observed and the prognostic significance of E-, N- and P-cadherin suggests the importance of these markers in bladder cancer progression. The poor patient prognosis in N-cadherin-negative muscle-invasive tumors indicates an alternative, N-cadherin-independent way in bladder cancer progression.

[1]  G. Gómez-López,et al.  Functional characterization of E- and P-cadherin in invasive breast cancer cells , 2009, BMC Cancer.

[2]  I. Kovalszky,et al.  Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer , 2008, Clinical Cancer Research.

[3]  M. Loda,et al.  P‐cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells , 2008, BJU international.

[4]  J. Jankowski,et al.  Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies , 2008, The Journal of pathology.

[5]  K. Gravdal,et al.  A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer , 2007, Clinical Cancer Research.

[6]  I. Sardi,et al.  E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study. , 2007, Oncology reports.

[7]  M. Loda,et al.  Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors , 2007, Clinical Cancer Research.

[8]  L. Kèlland.  Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization. , 2007, Current opinion in molecular therapeutics.

[9]  A. Rajasekaran,et al.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.

[10]  H. Wallerand,et al.  N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors , 2006, Clinical Cancer Research.

[11]  H. Kume,et al.  The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. , 2006, European urology.

[12]  O. Cussenot,et al.  Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. , 2005, European urology.

[13]  Carmen Jerónimo,et al.  P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation , 2005, Clinical Cancer Research.

[14]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[15]  G. de Rosa,et al.  P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas. , 2004, Histology and histopathology.

[16]  Avri Ben-Ze'ev,et al.  Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway , 2004, Oncogene.

[17]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.

[18]  L. Akslen,et al.  Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Huang,et al.  Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. , 2003, Cancer letters.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  P. Balaram,et al.  Cadherins as Predictive Markers of Nodal Metastasis in Breast Cancer , 2001, Modern Pathology.

[22]  I. Sardi,et al.  Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis. , 2000, International journal of molecular medicine.

[23]  C. Abbou,et al.  Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information , 2000, British Journal of Cancer.

[24]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[25]  S. Imamura,et al.  Multiple cadherins are expressed in human fibroblasts. , 1997, Biochemical and biophysical research communications.

[26]  R. Hazan,et al.  N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. , 1997, Cell adhesion and communication.

[27]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[28]  J. Schalken,et al.  Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. , 1993, Cancer research.

[29]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[30]  J. Schalken,et al.  Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: Biological significance and clinical implications , 1993, Cancer and Metastasis Reviews.

[31]  R. Hynes,et al.  Extrajunctional distribution of N-cadherin in cultured human endothelial cells. , 1992, Journal of cell science.

[32]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[33]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[34]  K. Rieger-Christ,et al.  Expression of classic cadherins type I in urothelial neoplastic progression. , 2001, Human pathology.

[35]  J. Schalken,et al.  Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. , 1999, International journal of cancer.